Dr Said Ismail, director of Qatar Genome Programme discusses the key ethical questions of precision medicine and what the industry needs to do to overcome them
Deanna Mudie, principal scientist at Lonza looks at how to increase the robustness of oral drug products and accelerate their development with biorelevant dissolution media.
Peter Cusworth, account manager for industrial automation company Yokogawa explores the challenges pharmaceutical manufacturers in the UK are facing when it comes to data integrity.
Christophe Hilbert, senior manager of Access, Value, and Evidence Strategy, Europe at bluebird bio explores the problems of pricing and reimbursement for gene and cell therapies in Europe.
Ian Bolland is joined by Dr Anne Blackwood from Health Enterprise East. Following on from a previous discussion about equality and diversity in medtech, they delve into more about a potential culture change when it comes to making innovations stick p
EPM speaks to technology company Lifebit about its collaboration with pharmaceutical organisation Boehringer to report on infectious disease outbreaks.
Jay McHarg, CEO of AeroSafe Global, discusses the importance of a sustainable, eco-friendly supply chain, how it's critical for pharmaceutical companies and how it can play a role in delivering better outcomes for both patients and the environment.
John Norman, technical service representative for the Tooling and Tablets division at Natoli examines the importance of both dimensional and visual tool inspections and their direct relationship to final tablet quality.
